4.8 Article

Total Synthesis of (+)-Discorhabdin V

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Endocrinology & Metabolism

Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia

Rodrigo A. Toledo et al.

Summary: The HIF2 alpha inhibitor belzutifan has been approved by the FDA as a treatment for certain tumors, opening up a new approach in cancer therapy. This article reviews the molecular rationale and clinical data for HIF2 alpha blockade, as well as discussing potential mutations that may be sensitive to this approach. Resistance mechanisms to HIF2 alpha inhibitors, including acquired mutations in HIF2 alpha and its interacting partner ARNT, are also outlined. The high efficacy of belzutifan in tumors driven by genetic hypoxia suggests that other mutations leading to HIF2 alpha stabilization should be further investigated.

ENDOCRINE REVIEWS (2023)

Article Chemistry, Organic

Construction of the Tetracyclic Framework of Sulfur-Containing Discorhabdin-Type Alkaloids

Qin Zhou et al.

Summary: We report an efficient synthetic method for constructing the tetracyclic scaffold of sulfur-containing discorhabdin-type alkaloids. This method involves a cascade reaction that converts a common and readily available N,O-acetal-bridged framework to a labile and synthetically challenging N,S-acetal-bridged framework in a single step. Additionally, intramolecular oxidative dearomatization promoted by hypervalent iodine and radical cyclization facilitated by indium-(III) acetate were also essential for this study.

ORGANIC LETTERS (2023)

Article Chemistry, Organic

Pyrroloiminoquinone Alkaloids: Total Synthesis of Makaluvamines A and K

Jason An et al.

Summary: This paper presents an efficient, scalable, and concise approach for the synthesis of an advanced pyrroloiminoquinone synthetic intermediate (6b) using Larock indole synthesis. The synthetic utility of this intermediate is demonstrated by its ready conversion to makaluvamines A (1) and K (4).

ORGANIC LETTERS (2023)

Article Chemistry, Multidisciplinary

Unified Divergent Total Synthesis of Discorhabdin B, H, K, and Aleutianamine via the Late-Stage Oxidative N,S-Acetal Formation

Masashi Shimomura et al.

Summary: This study successfully achieved the total syntheses of (+)-discorhabdin B, (-)-discorhabdin H, (+)-discorhabdin K, and (-)-aleutianamine. A phenethylamine fragment bearing a o-pivaloylthiogroup, corresponding to the D/E/G ring moiety, was prepared and subjected to oxidative spirocyclization to furnish the spirocyclohexadienone. The key construction of the highly strained Gring with the N,S-acetal moiety and the site- and face-selective thia-michael addition were utilized for the synthesis of (-)-discorhabdin H and (+)-discorhabdin K. The total synthesis of (-)-aleutianamine was achieved through a skeletal rearrangement initiated by the Luche reduction.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2023)

Review Biochemistry & Molecular Biology

Current Perspectives on Pyrroloiminoquinones: Distribution, Biosynthesis and Drug Discovery Potential

Jarmo-Charles J. Kalinski et al.

Summary: Pyrroloiminoquinones are cytotoxic alkaloids commonly found in marine sponges. They have a tricyclic pyrrolo[4,3,2-de]quinoline core and exhibit a wide range of biological activities, including anticancer, antiplasmodial, antimicrobial, antifungal, and antiviral activities. This review provides a concise summary of their structural diversity, distribution, biogenesis, and potential as chemical probes for drug development, including discussion on promising synthetic analogs.

MOLECULES (2022)

Article Oncology

FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors

Jaleh Fallah et al.

Summary: On August 13, 2021, FDA approved belzutifan for the treatment of certain conditions in patients with von Hippel-Lindau (VHL) disease. The approval was based on the observed overall response rate and duration, as well as the common adverse reactions.

CLINICAL CANCER RESEARCH (2022)

Review Biochemistry & Molecular Biology

Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development

Rituparna Ghosh et al.

Summary: Advancement in novel target detection using improved molecular cancer biology has opened up new avenues for promising anti-cancer drug development. HIF-1 alpha, a major transcriptional regulator, plays a crucial role in tumor adaptation to hypoxia and regulates various biological processes involved in tumorigenesis. Inhibitors targeting HIF-1 alpha have been considered as a novel cancer therapeutic strategy, holding potential for accelerated anticancer drug discovery.

MOLECULES (2022)

Review Medicine, Research & Experimental

Hypoxia-inducible factors: cancer progression and clinical translation

Elizabeth E. Wicks et al.

Summary: This review presents the mechanisms and consequences of hypoxia-inducible factor (HIF) activation in cancer cells, and discusses the current status and future prospects of small-molecule HIF inhibitors as cancer therapeutics.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Chemistry, Organic

Synthetic studies on discorhabdin V: Construction of the A-F hexacyclic framework

Takahiro Noro et al.

Summary: This paper describes the synthetic studies of a discorhabdin alkaloid with C2-N18 bond, which includes A-F hexa-cyclic framework. The specific bond was formed by Mitsunobu reaction, and later a tricyclic o-quinone intermediate was obtained through an aerobic oxidative cascade cyclization. In the later stage of the synthesis, complex ring systems were constructed using intramolecular Heck cyclization of the halogenated tricyclic o-quinone.

TETRAHEDRON LETTERS (2021)

Review Biochemistry & Molecular Biology

Small molecules targeting HIF-1α pathway for cancer therapy in recent years

Wendi Tang et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2020)

Article Chemistry, Organic

Divergent Total Syntheses of Isobatzellines A/B and Batzelline A

Yumi Yamashita et al.

ORGANIC LETTERS (2020)

Review Oncology

HIF Inhibitors: Status of Current Clinical Development

Jaleh Fallah et al.

CURRENT ONCOLOGY REPORTS (2019)

Article Chemistry, Organic

Total Synthesis of Mycenarubin A, Sanguinolentaquinone and Mycenaflavin B and their Cytotoxic Activities

Jana Backenkoehler et al.

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2018)

Article Chemistry, Medicinal

Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models

Emily M. Harris et al.

MARINE DRUGS (2018)

Article Chemistry, Organic

Investigation of the electrophilic reactivity of the cytotoxic marine alkaloid discorhabdin B

Cary F. C. Lam et al.

ORGANIC & BIOMOLECULAR CHEMISTRY (2012)

Review Chemistry, Multidisciplinary

Discorhabdins and Pyrroloiminoquinone-Related Alkaloids

Jin-Feng Hu et al.

CHEMICAL REVIEWS (2011)

Article Chemistry, Multidisciplinary

Highly Practical Copper(I)/TEMPO Catalyst System for Chemoselective Aerobic Oxidation of Primary Alcohols

Jessica M. Hoover et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)

Article Plant Sciences

Discorhabdins from the Korean Marine Sponge Sceptrella sp.

Ju-eun Jeon et al.

JOURNAL OF NATURAL PRODUCTS (2010)

Article Chemistry, Multidisciplinary

Assigning Stereochemistry to Single Diastereoisomers by GIAO NMR Calculation: The DP4 Probability

Steven G. Smith et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)

Article Chemistry, Medicinal

Semi-synthetic preparation of the rare, cytotoxic, deep-sea sourced sponge metabolites discorhabdins P and U

T Grkovic et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)

Review Biochemistry & Molecular Biology

Pyrroloiminoquinone and related metabolites from marine sponges

EM Antunes et al.

NATURAL PRODUCT REPORTS (2005)

Article Plant Sciences

Cytotoxic pyrroloiminoquinones from four new species of south African latrunculid sponges

EM Antunes et al.

JOURNAL OF NATURAL PRODUCTS (2004)

Article Chemistry, Multidisciplinary

The first total synthesis of discorhabdin A

H Tohma et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)

Article Chemistry, Organic

Regioselective oxidation of phenols to o-quinones with o-iodoxybenzoic acid (IBX)

D Magdziak et al.

ORGANIC LETTERS (2002)